Last updated on August 2018

Patients are needed to participate in a clinical research study for the treatment of Influenza


Brief description of study

The randomized, observer-blind non-influenza comparator controlled study is intended to demonstrate the efficacy, immunogenicity, safety and tolerability of Seqirus' cell-based inactivated quadrivalent vaccine (QIVc) in subjects 2 years to <18 years of age

Clinical Study Identifier: NCT03165617

Contact Investigators or Research Sites near you

Start Over

AusTrials Pty Ltd
Sherwood, Australia